HomepageBT3 • FRA
add
BioTime
Vorige slotkoers
€ 0,46
Dag-range
€ 0,46 - € 0,46
Jaar-range
€ 0,44 - € 1,33
Beurswaarde
115,00Â mln. USD
Gem. volume
546,00
Koers/winst
-
Dividendrendement
-
Marktnieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
(USD) | dec 2024info | Wijziging j-o-j |
---|---|---|
Opbrengst | 2,87Â mln. | 37,36% |
Bedrijfskosten | 4,40Â mln. | 480,61% |
Netto inkomsten | -3,27Â mln. | 31,46% |
Netto winstmarge | -114,12 | 50,10% |
Winst per aandeel | -0,01 | 63,24% |
EBITDA | -4,96Â mln. | -86,64% |
Effectief belastingtarief | — | — |
Balans
Totale activa
Totale passiva
(USD) | dec 2024info | Wijziging j-o-j |
---|---|---|
Contanten en kortetermijnbeleggingen | 47,80Â mln. | 34,69% |
Totale activa | 113,22Â mln. | 12,08% |
Totale passiva | 36,21Â mln. | -7,15% |
Totaal aandelenvermogen | 77,01 mln. | — |
Uitstaande aandelen | 228,36 mln. | — |
Koers-boekwaardeverhouding | 1,27 | — |
Rendement op activa | -12,18% | — |
Rendement op kapitaal | -17,37% | — |
Kasstroom
Nettomutatie in liquide middelen
(USD) | dec 2024info | Wijziging j-o-j |
---|---|---|
Netto inkomsten | -3,27Â mln. | 31,46% |
Operationele kasstroom | -6,35Â mln. | -5,43% |
Kasstroom uit beleggingen | 2,64Â mln. | -72,95% |
Kasstroom uit financiering | 21,73Â mln. | 167.284,62% |
Nettomutatie in liquide middelen | 18,05Â mln. | 352,10% |
Vrije kasstroom | -3,50Â mln. | -594,59% |
Over
Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. With this platform Lineage develops and manufactures specialized, terminally differentiated human cells from its pluripotent and progenitor cell starting materials. These differentiated cells are developed to either replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer. Wikipedia
Opgericht
1990
Website
Werknemers
74